Molecular minimal residual disease negativity and decreased stem cell mobilization potential predict excellent outcome after autologous transplant in mutant acute myeloid leukemia.
作者信息
de Benito Alvaro de Santiago, Jeker Barbara, Gfeller Eva, Porret Naomi, Banz Yara, Novak Urban, Bacher Ulrike, Pabst Thomas
机构信息
Department of Medical Oncology, Inselspital, University Hospital and University of Bern, Bern.
Center for Hemato-Oncology, University Cancer Institute; University Hospital and University of Bern, Bern.
出版信息
Haematologica. 2020 Jan;105(1):e9-e12. doi: 10.3324/haematol.2019.216457. Epub 2019 May 23.
Abstract
摘要
相似文献
1
Molecular minimal residual disease negativity and decreased stem cell mobilization potential predict excellent outcome after autologous transplant in mutant acute myeloid leukemia.
Haematologica. 2020 Jan;105(1):e9-e12. doi: 10.3324/haematol.2019.216457. Epub 2019 May 23.
2
Digital droplet PCR-based absolute quantification of pre-transplant NPM1 mutation burden predicts relapse in acute myeloid leukemia patients.
Ann Hematol. 2018 Oct;97(10):1757-1765. doi: 10.1007/s00277-018-3373-y. Epub 2018 May 22.
3
Minimal/Measurable Residual Disease Monitoring in -Mutated Acute Myeloid Leukemia: A Clinical Viewpoint and Perspectives.
Int J Mol Sci. 2018 Nov 6;19(11):3492. doi: 10.3390/ijms19113492.
4
Pretransplant NPM1 MRD levels predict outcome after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia.
Blood Cancer J. 2016 Jul 29;6(7):e449. doi: 10.1038/bcj.2016.46.
5
Pre-transplant Quantitative Determination of NPM1 Mutation Significantly Predicts Outcome of AIlogeneic Hematopoietic Stem Cell Transplantation in Patients with Normal Karyotype AML in Complete Remission.
Anticancer Res. 2016 Oct;36(10):5487-5498. doi: 10.21873/anticanres.11130.
6
Monitoring of minimal residual disease in NPM1-mutated acute myeloid leukemia: a study from the German-Austrian acute myeloid leukemia study group.
J Clin Oncol. 2011 Jul 1;29(19):2709-16. doi: 10.1200/JCO.2011.35.0371. Epub 2011 May 9.
7
Minimal residual disease detection in acute myeloid leukemia by mutant nucleophosmin (NPM1): comparison with WT1 gene expression.
Clin Chim Acta. 2008 Sep;395(1-2):120-3. doi: 10.1016/j.cca.2008.05.021. Epub 2008 Jun 8.
8
Minimal residual disease assessed with deep sequencing of NPM1 mutations predicts relapse after allogeneic stem cell transplant in AML.
Leuk Lymphoma. 2019 Feb;60(2):409-417. doi: 10.1080/10428194.2018.1485910. Epub 2018 Aug 2.
9
Minimal residual disease-directed preemptive treatment with azacitidine in patients with NPM1-mutant acute myeloid leukemia and molecular relapse.
Haematologica. 2011 Oct;96(10):1568-70. doi: 10.3324/haematol.2011.044388. Epub 2011 Jul 12.
10
High NPM1 mutant allele burden at diagnosis correlates with minimal residual disease at first remission in de novo acute myeloid leukemia.
Am J Hematol. 2019 Aug;94(8):921-928. doi: 10.1002/ajh.25544. Epub 2019 Jun 17.
引用本文的文献
1
Safety and Efficacy of High-Dose Chemotherapy with TreoMel 200 vs. TreoMel 140 in Acute Myeloid Leukemia Patients Undergoing Autologous Stem Cell Transplantation.
Cancers (Basel). 2024 May 15;16(10):1887. doi: 10.3390/cancers16101887.
2
Comparison of Melphalan Combined with Treosulfan or Busulfan as High-Dose Chemotherapy before Autologous Stem Cell Transplantation in AML.
Cancers (Basel). 2022 Feb 17;14(4):1024. doi: 10.3390/cancers14041024.
3
Feasibility and efficacy of salvage allogeneic stem cell transplantation in AML patients relapsing after autologous stem cell transplantation.
Bone Marrow Transplant. 2022 Feb;57(2):224-231. doi: 10.1038/s41409-021-01521-5. Epub 2021 Nov 13.
4
Clonal Hematopoiesis after Autologous Stem Cell Transplantation Does Not Confer Adverse Prognosis in Patients with AML.
Cancers (Basel). 2021 Jun 25;13(13):3190. doi: 10.3390/cancers13133190.
5
The Role of Measurable Residual Disease (MRD) in Hematopoietic Stem Cell Transplantation for Hematological Malignancies Focusing on Acute Leukemia.
Int J Mol Sci. 2019 Oct 28;20(21):5362. doi: 10.3390/ijms20215362.
本文引用的文献
1
Autologous Transplantation for Older Adults with AML.
Cancers (Basel). 2018 Sep 19;10(9):340. doi: 10.3390/cancers10090340.
2
Iron overload is correlated with impaired autologous stem cell mobilization and survival in acute myeloid leukemia.
Transfusion. 2018 Oct;58(10):2365-2373. doi: 10.1111/trf.14895. Epub 2018 Sep 10.
3
Measurable residual disease, conditioning regimen intensity, and age predict outcome of allogeneic hematopoietic cell transplantation for acute myeloid leukemia in first remission: A registry analysis of 2292 patients by the Acute Leukemia Working Party European Society of Blood and Marrow Transplantation.
Am J Hematol. 2018 Sep;93(9):1142-1152. doi: 10.1002/ajh.25211. Epub 2018 Aug 15.
4
Pitfalls in the molecular follow up of mutant acute myeloid leukemia.
Haematologica. 2018 Oct;103(10):e486-e488. doi: 10.3324/haematol.2018.192104. Epub 2018 Jun 14.
5
Unrelated matched versus autologous transplantation in adult patients with good and intermediate risk acute myelogenous leukemia in first molecular remission.
Am J Hematol. 2017 Dec;92(12):1318-1323. doi: 10.1002/ajh.24904. Epub 2017 Sep 28.
6
Consolidation with autologous stem cell transplantation in first remission is safe and effective in AML patients above 65 years.
Leuk Res. 2017 Feb;53:28-34. doi: 10.1016/j.leukres.2016.12.001. Epub 2016 Dec 8.
7
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel.
Blood. 2017 Jan 26;129(4):424-447. doi: 10.1182/blood-2016-08-733196. Epub 2016 Nov 28.
8
Assessment of Minimal Residual Disease in Standard-Risk AML.
N Engl J Med. 2016 Feb 4;374(5):422-33. doi: 10.1056/NEJMoa1507471. Epub 2016 Jan 20.
9
Delayed Haematological recovery after autologous stem cell transplantation is associated with favourable outcome in acute myeloid leukaemia.
Br J Haematol. 2015 Jan;168(2):268-73. doi: 10.1111/bjh.13118. Epub 2014 Sep 12.
10
The relapse risk of AML patients undergoing autologous transplantation correlates with the stem cell mobilizing potential.
Leuk Res. 2012 Nov;36(11):1325-9. doi: 10.1016/j.leukres.2012.05.027. Epub 2012 Jun 23.
Zotero 插件